0001144204-19-039455.txt : 20190813 0001144204-19-039455.hdr.sgml : 20190813 20190813140509 ACCESSION NUMBER: 0001144204-19-039455 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190809 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20190813 DATE AS OF CHANGE: 20190813 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Summit Healthcare REIT, Inc CENTRAL INDEX KEY: 0001310383 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 731721791 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-52566 FILM NUMBER: 191019821 BUSINESS ADDRESS: STREET 1: 2 SOUTH POINTE DRIVE STREET 2: STE 100 CITY: LAKE FOREST STATE: CA ZIP: 92630 BUSINESS PHONE: 949-535-2022 MAIL ADDRESS: STREET 1: 2 SOUTH POINTE DRIVE STREET 2: STE 100 CITY: LAKE FOREST STATE: CA ZIP: 92630 FORMER COMPANY: FORMER CONFORMED NAME: Cornerstone Core Properties REIT, Inc. DATE OF NAME CHANGE: 20050518 FORMER COMPANY: FORMER CONFORMED NAME: Cornerstone Core Properties REIT DATE OF NAME CHANGE: 20050516 FORMER COMPANY: FORMER CONFORMED NAME: Cornerstone Realty Fund Inc DATE OF NAME CHANGE: 20041202 8-K 1 tv527547_8k.htm FORM 8-K

 

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

____________________

 

FORM 8-K

____________________

 

CURRENT REPORT

 

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (date of earliest event reported):

 

August 9, 2019

 

SUMMIT HEALTHCARE REIT, INC.

(Exact name of registrant as specified in its charter)

____________________

 

Maryland 000-52566 73-1721791
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)

 

2 South Pointe Drive, Suite 100, Lake Forest, California 92630

(Address of principal executive offices)

 

(800) 978-8136

(Registrant's telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

____________________

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act.
¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act.
¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Ticker symbol(s) Name of each exchange on which registered
N/A N/A N/A

 

 

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

  

On August 9, 2019, the Board of Directors of Summit Healthcare REIT, Inc. (the “Company”) elected the following persons to the offices of the Company as set forth below opposite their respective names, effective immediately, to each hold office until the earlier appointment and qualification of their respective successors or until their earlier death, resignation or removal:

 

  Name Office(s)
  Kent Eikanas Chief Executive Officer
  Elizabeth Pagliarini Chief Operating Officer and Chief Financial Officer

  

The descriptions of Mr. Eikanas and Ms. Pagliarini in the Company’s proxy statement filed with the Securities & Exchange Commission on June 24, 2019, including with respect to their experience and executive compensation, are hereby incorporated by reference.

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

  SUMMIT HEALTHCARE REIT, INC.  
       
  By: /s/ Elizabeth A. Pagliarini  
  Name: Elizabeth A. Pagliarini  
  Title: Chief Financial Officer  

  

Dated: August 13, 2019